The Redefining Early Stage Investments (RESI) Conference is back in Boston on September 16, and we are looking for innovative life science companies to participate in the RESI Innovation Challenge. If you are a scientist-entrepreneur or fundraising CEO actively looking for raising capital, the RESI Innovation Challenge is for you.

Out of hundreds of applicants, Life Science Nation's internal scientific review board will choose the top 30 companies to present their technologies in an exhibition-style format throughout the full-day conference. Presenters will gain additional exposure to investors and potential partners by showcasing their companies and products in a poster board format. Unlike traditional 5- to 15-minute pitch presentations that do not allow any real one-on-one interaction and provide no actionable feedback from investors, the RESI Innovation Challenge enables executives to pitch directly to attendees, which can generate more in-depth and frequent conversations with investors throughout the event...

  READ MORE

The Large Pharma Panel at RESI is always one of the most popular and RESI@TMCx was no exception. This panel featuring representatives from Johnson and Johnson, Boehringer Ingelheim, Bristol Myers Squibb, Takeda Ventures, and Sanofi discusses the specific areas where these groups are looking to make allocations and how companies should go about getting on their radar. Other topics addressed include why big pharma is looking early stage and how big pharma looks to partner with big medtech and foundations/venture philanthropy groups to move science forward.

To hear firsthand big pharma's opinion on these topics, watch this RESI video recap.

  READ MORE

RESI@TMCx Big Pharma Panel